[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drugs for Malaria Market Survey and Trend Research 2018

December 2017 | 80 pages | ID: G0AADE661F2EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Guilin Pharmaceutical, Cipla, IPCA Laboratories, GlaxoSmithKline, Roche, Roche, Novartis, Sanofi Aventis, Ajanta Pharma etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
1 PART 1 INDUSTRY OVERVIEW

1.1 Drugs for Malaria Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

1 PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

1 PART 3 DRUGS FOR MALARIA MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Guilin Pharmaceutical (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Cipla (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 IPCA Laboratories (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 GlaxoSmithKline (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Roche (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Roche (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Novartis (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Sanofi Aventis (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Ajanta Pharma (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis

1 PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

1 PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

1 PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

1 PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

1 PART 9 CONCLUSION

LIST OF TABLES

Table Global Drugs for Malaria Market 2012-2017, by Type, in USD Million
Table Global Drugs for Malaria Market 2012-2017, by Type, in Volume
Table Global Drugs for Malaria Market Forecast 2018-2023, by Type, in USD Million
Table Global Drugs for Malaria Market Forecast 2018-2023, by Type, in Volume
Table Guilin Pharmaceutical Overview List
Table Drugs for Malaria Business Operation of Guilin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Drugs for Malaria Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table IPCA Laboratories Overview List
Table Drugs for Malaria Business Operation of IPCA Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Drugs for Malaria Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Drugs for Malaria Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Drugs for Malaria Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Drugs for Malaria Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Aventis Overview List
Table Drugs for Malaria Business Operation of Sanofi Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ajanta Pharma Overview List
Table Drugs for Malaria Business Operation of Ajanta Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Drugs for Malaria Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Drugs for Malaria Sales Revenue Share, by Companies, in USD Million
Table Global Drugs for Malaria Sales Volume 2012-2017, by Companies, in Volume
Table Global Drugs for Malaria Sales Revenue Share, by Companies in 2017, in Volume
Table Drugs for Malaria Demand 2012-2017, by Application, in USD Million
Table Drugs for Malaria Demand 2012-2017, by Application, in Volume
Table Drugs for Malaria Demand Forecast 2018-2023, by Application, in USD Million
Table Drugs for Malaria Demand Forecast 2018-2023, by Application, in Volume
Table Global Drugs for Malaria Market 2012-2017, by Region, in USD Million
Table Global Drugs for Malaria Market 2012-2017, by Region, in Volume
Table Drugs for Malaria Market Forecast 2018-2023, by Region, in USD Million
Table Drugs for Malaria Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Drugs for Malaria Industry Chain Structure
Figure Global Drugs for Malaria Market Growth 2012-2017, by Type, in USD Million
Figure Global Drugs for Malaria Market Growth 2012-2017, by Type, in Volume
Figure Global Drugs for Malaria Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Drugs for Malaria Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications